rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2011-3-16
|
pubmed:abstractText |
The Centers for Disease Control and Prevention recommend hospitals develop guidelines for the appropriate use of vancomycin as part of comprehensive antimicrobial stewardship. The objective of this study was to evaluate the effectiveness and safety of a guideline to restrict vancomycin use in the neonatal intensive care unit (NICU).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1532-0987
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
273-8
|
pubmed:meshHeading |
pubmed-meshheading:21085051-Anti-Bacterial Agents,
pubmed-meshheading:21085051-Bacterial Infections,
pubmed-meshheading:21085051-Drug Utilization,
pubmed-meshheading:21085051-Guideline Adherence,
pubmed-meshheading:21085051-Health Services Research,
pubmed-meshheading:21085051-Humans,
pubmed-meshheading:21085051-Infant, Newborn,
pubmed-meshheading:21085051-Intensive Care, Neonatal,
pubmed-meshheading:21085051-Massachusetts,
pubmed-meshheading:21085051-Organizational Policy,
pubmed-meshheading:21085051-Vancomycin
|
pubmed:year |
2011
|
pubmed:articleTitle |
Effectiveness of a guideline to reduce vancomycin use in the neonatal intensive care unit.
|
pubmed:affiliation |
Division of Newborn Medicine, Children's Hospital, Boston, MA, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|